Specialty
Certifications
Hematology
Clinical Focus
Education
MD, Universidad Nacional De Rosario
Residency, Internal Medicine
Universidad Nacional De RosarioResidency, Medicine/Hematology
New England Medical CenterResidency, Internal Medicine
West Suburban Hospital Medical Ctr.Fellowship, Hematology-Oncology
Mount Sinai HospitalFellowship, Bone Marrow Trans.
Mount Sinai Hospital
Awards
1991 -
Honour Diploma (Summa cum Laude)
National University of Rosario
Publications
DuHamel KN, Mosher CE, Winkel G, Labay LE, Rini C, Meschian YM, Austin J, Greene PB, Lawsin CR, Rusiewicz A, Grosskreutz CL, Isola L, Moskowitz CH, Papadopoulos EB, Rowley S, Scigliano E, Burkhalter JE, Hurley KE, Bollinger AR, Redd WH. Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Aug; 28(23).
Osman K, Elliott B, Mandeli J, Scigliano E, Malone A, Isola L, Grosskreutz C. Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma. American journal of hematology 2010 Apr; 85(4).
Mosher CE, DuHamel KN, Rini CM, Li Y, Isola L, Labay L, Rowley S, Papadopoulos E, Moskowitz C, Scigliano E, Grosskreutz C, Redd WH. Barriers to mental health service use among hematopoietic SCT survivors. Bone marrow transplantation 2010 Mar; 45(3).
Grosskreutz C, Gudzowaty O, Shi P, Rodriguez-Laiz G, Malone A, Isola L. Partial HLA matching and RH incompatibility resulting in graft versus host reaction and Evans syndrome after liver transplantation. American journal of hematology 2008 Jul; 83(7).
Grosskreutz C, Scigliano E, Osman K, Isola L. Graft versus host disease after stem cell allotransplantation with low-dose total body irradiation, fludarabine, and antithymocyte globulin. Transplantation 2007 Sep; 84(5).
Grosskreutz C, Ross V, Scigliano E, Fruchtman S, Isola L. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003 Jul; 9(7).
Grosskreutz C, Troy K, Cuttner J. Primary splenic lymphoma: report of 10 cases using the REAL classification. Cancer investigation 2002; 20(5-6).
Clinical Trials
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Grosskreutz did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Icahn Medical Institute Floor 3rd Room L26
1425 Madison Avenue
New York, NY 10029
Fax: 212-241-4628
1470 Madison Avenue
New York, NY 10029
- Monday 8:30am - 5:00pm
- Tuesday 1:00pm - 5:00pm
- Wednesday 1:00pm - 5:00pm
- Thursday 8:30am - 1:30pm
- Friday 8:30am - 1:30pm
- Spanish